References
Dalmau J, Gleichman AJ, Hughes EG et al (2008) Anti-NMDAR-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 7(12):1091–1098
Dalmau J, Lancester E, Martinez-Hernandez E et al (2011) Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 10(1):63–74
Gresa-Arribas N, Titulaer MJ, Torrents A et al (2014) Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study. Lancet Neurol 13(2):167–177
Armangue T, Titulaer MJ, Sabater L et al (2014) A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma. Ann Neurol 75(3):435–441
North WG, Gao G, Jensen A et al (2010) NMDA receptors are expressed by small-cell lung cancer are potential targets for effective treatment. Chin Pharmacol 2:31–40
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Wu, YY., He, XJ., Zhang, ML. et al. Anti-N-methyl-d-aspartate receptor encephalitis with lung adenocarcinoma. Neurol Sci 37, 1573–1575 (2016). https://doi.org/10.1007/s10072-016-2563-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-016-2563-4